PedAM
Pediatric Disease Annotations & Medicines
| Disease | polycystic kidney diseases |
| Phenotype | C0020538|hypertension |
| Sentences | 11 |
| PubMedID- 25030010 | Sympathetic overactivity plays a crucial role in the genesis and aggravation of arterial hypertension in patients with autosomal dominant polycystic kidney disease (adpkd). |
| PubMedID- 20882096 | Background: enlargement of renal size plays an important role in the development of hypertension in patients with autosomic dominant polycystic kidney disease (adpkd) and normal renal function. |
| PubMedID- 26254120 | Pheochromocytoma as a rare cause of arterial hypertension in a patient with autosomal dominant polycystic kidney disease: a diagnostic and therapeutic dilemma. |
| PubMedID- 22902029 | Purpose: cyst proliferation in patients with autosomal dominant polycystic kidney disease is associated with renal failure, hypertension and pain. |
| PubMedID- 25190938 | [8] infection, trauma, diseases associated with hypertension like coarctation of aorta, polycystic kidney disease and deficiency of type iii collagen have been seen to be associated with cerebral aneurysm and sah. |
| PubMedID- 25999403 | The mechanism for early hypertension in polycystic kidney disease (pkd) has not been elucidated. |
| PubMedID- 23971640 | hypertension in children with autosomal dominant polycystic kidney disease (adpkd). |
| PubMedID- 23808746 | hypertension is common in patients with autosomal dominant polycystic kidney disease (adpkd) very early usually already in adolescence and its occurrence precedes the decrease of glomerular filtration rate. |
| PubMedID- 21962616 | polycystic kidney disease presenting with hypertension and hypokalemia. |
| PubMedID- 25399731 | Background: hypertension develops early in patients with autosomal dominant polycystic kidney disease (adpkd) and is associated with disease progression. |
| PubMedID- 24748884 | The title of our clinical protocols was dopamine receptor in hypertension with polycystic kidney disease (no. |
Page: 1